Novartis
Novartis articles from Informachine.
Novartis expands India’s role in global drug development and R&D
By Axel Miller | 11 May 2026
Novartis is expanding India’s role in pharmaceutical R&D, clinical research and innovative medicines following its strategic restructuring in the country.
Novartis to buy breast cancer drug candidate from Synnovation in up to $3 billion deal
By Axel Miller | 20 Mar 2026
Novartis will acquire a breast cancer drug candidate from Synnovation Therapeutics in a deal worth up to $3 billion, boosting its oncology pipeline.
Novartis India refutes media reports of negotiations with Alkem Labs
27 Sep 2024
Novartis India, has refuted media reports stating that its parent company is in talks with Mumbai-based Alkem Labs for sale of the Indian arm.
Siemens Healthineers submits binding offer for Novartis’s molecular imaging business
27 Aug 2024
Siemens Healthiness AG is reported to have submitted a binding offer for acquiring the molecular imaging business of Swiss Drugmaker Novartis.
Novartis to acquire US-based Mariana Oncology in $1.75 bn deal
03 May 2024
Swiss drug maker Novartis has agreed to acquire US-based Mariana Oncology in a deal worth $1.75 billion, as the company seeks advance the development of precision treatment for cancer.
Novartis announces strategic review of its India business
19 Feb 2024
Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.
Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.
Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!
Latest articles on Novartis from Informachine
Small shifts. Big impact. The leadership choices that matter most in the age of AI | Novartis
05 Aug 2026
There is no shortage of conversation about what AI can do. Every day brings a new headline, a new capability, a new prediction about how work will change.
How Novartis R&D is advancing the next breakthrough innovations | Novartis
05 Aug 2026
We’re tackling medicine’s toughest challenges through disease expertise and technological leadership to deliver breakthroughs that matter to patients.
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next | Novartis
05 Aug 2026
The roots of Novartis reach back more than 250 years, to the chemical and scientific traditions that helped shape modern healthcare. Thirty years after its creation, that legacy of curiosity continues
